Prospective Clinical Study to Evaluate the Efficacy of the Stand-alone Cervical Interbody Cage C-CURVE ( Titanium) Manufactured by MEDICREA® (C-CURVE)

January 9, 2025 updated by: Medicrea International

Prospective Clinical Study to Evaluate the Efficacy of the Stand-alone Cervical Interbody Cage C-CURVE (Titanium) Manufactured by MEDICREA®

This study includes one type of product named C-CURVE which is a Stand-alone Cervical Interbody Cage. This product is available in two materials: PEEK and Titanium.

The C-Curve Cervical Interbody Devices is one single implant used for insertion between two adjacent vertebrae (cervical spine). C-Curve has been designed to restore and/or maintain adequate interbody height, and thus help stabilize one or more cervical levels while fusion occurs. This system has also as objectives to increase of the quality of life, decrease patient's pain and decrease a potential dysphagia (clinical performances). This system must only be used in the cervical spine.

This post-market clinical follow-up (PMCF) study aims to confirm the acceptable benefits/risk profile of the device for the patients and to fill essential requirements to maintain the CE mark through a clinical evaluation.

Study Overview

Study Type

Interventional

Enrollment (Actual)

82

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Tournai, Belgium
        • CH Wapi
      • Bayonne, France
        • Clinique Belharra
      • Castelnau-le-Lez, France
        • Clinique du Parc
      • La Rochelle, France
        • Groupe Hospitalier La Rochelle-Ré-Aunis
      • Lyon, France
        • Centre de consultations spécialisées de la Sauvegarde
      • Lyon, France
        • Centre Orthopedique Santy
      • Marseille, France
        • Clinique Clairval
      • Saint-Jean, France, 31240
        • Clinique de l'Union
      • Sainte-Foy-lès-Lyon, France
        • Clinique Charcot
      • Tours, France
        • CHRU Bretonneau

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patient operated with C-CURVE TITANIUM (MEDICREA) for one or several levels (3 maximum)
  • Cage implanted with the bone graft "OSMOSYS" (MEDICREA) or an auto bone graft from patients
  • Patient ≥ 18 years
  • Patient affiliated to health care insurance (social security in France)
  • Patient who signed an informed consent form
  • Patient able and willing to complete a self-administered questionnaire
  • Patient able to understand protocol and the planning visit and willing to perform all of them
  • Patient with a pathology indicated in the instruction for use of the implant

Exclusion Criteria:

  • Patient with no preoperative data available (X-rays, questionnaires)
  • Hybrid installation or cervical additional fixation
  • Patient contraindicated for X-ray(s) and/or CT-Scan(s)
  • Patient with contraindications indicated in the instruction for use of the implant
  • Patient judged as non-compliant by the investigator, not unable to come back for the follow-up visits (for example: patient living more than 100 km away).
  • Patient who declined to participate to the study or unable to give his consent Vulnerable population as explained in the protocol

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: C-CURVE Titane
According the routine practice of the investigator surgeon, the interbody cage C-CURVE in Titane is used
ACDF: Anterior Cervical Discectomy and Fusion with a C-CURVE cage

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fusion of the cervical interbody cage used
Time Frame: 24 months
Measures the bone fusion thanks to the CTscan
24 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fusion of the cervical interbody cage used
Time Frame: 6, 12 and 24 months
Measures the bone fusion thanks to the Xrays
6, 12 and 24 months
Quality of life with modified SF-12
Time Frame: Preoperative, and 6, 12 and 24 months postoperative
Score of the modified SF-12 (to 0 (better) to 100 (worst)
Preoperative, and 6, 12 and 24 months postoperative
Satisfaction patient
Time Frame: 6, 12 and 24 months
Score of the PSI (scale: 1/2/3/4 ; 1: Better)
6, 12 and 24 months
VAS (Pain)
Time Frame: Preoperative, and 6, 12 and 24 months postoperative
Score of the pain (to 0 (better) to 10 (worst)
Preoperative, and 6, 12 and 24 months postoperative
NDI(Neck Disability Index)
Time Frame: Preoperative, and 6, 12 and 24 months postoperative
Score of the pain (to 0 (better) to 50 (worst)
Preoperative, and 6, 12 and 24 months postoperative
Cervical spinal radiographic parameters (Cobb angle, C2C7 angle, Segmental lordosis/kyphosis, disk height, subsidence, alignment restauration ) for C-CURVE Titanium only
Time Frame: Preoperative, and 6, 12 and 24 months postoperative
radiographic measurements
Preoperative, and 6, 12 and 24 months postoperative
Complications
Time Frame: peroperative and 6, 12 and 24 months postoperative
All Adverse Events related to the study device, instruments and/or the study procedure and all SAEs must be reported
peroperative and 6, 12 and 24 months postoperative
Fusion of the cervical interbody cage used
Time Frame: 6 and 12 months postoperative
Measures the bone fusion thanks to the CTscan
6 and 12 months postoperative

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 20, 2020

Primary Completion (Actual)

October 1, 2024

Study Completion (Actual)

October 1, 2024

Study Registration Dates

First Submitted

September 7, 2020

First Submitted That Met QC Criteria

September 7, 2020

First Posted (Actual)

September 14, 2020

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

January 9, 2025

Last Verified

January 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cervical Disc Disease

Clinical Trials on cervical interbody cage C-CURVE

Subscribe